Dennis E. Marshall - 31 Mar 2022 Form 4 Insider Report for BIOLARGO, INC. (BLGO)

Role
Director
Signature
/s/ John R. Browning, Attorney-in-fact
Issuer symbol
BLGO
Transactions as of
31 Mar 2022
Net transactions value
$0
Form type
4
Filing time
04 Apr 2022, 17:43:38 UTC
Previous filing
04 Jan 2022
Next filing
05 Jul 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BLGO Option to purchase common stock Award $0 +208,377 +6.5% $0.000000 3,405,846 31 Mar 2022 Common stock 208,377 $0.2300 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Option was granted to Reporting Person to replace option(s) previously issued in lieu of cash compensation to Reporting Person for services provided to the Issuer, which expired, unexercised, due to a discrepancy between the original exercise price of the Option and the current stock price of the Issuer, pursuant to plan adopted by the Issuer's Compensation Committee and Board of Directors.